Gulsen Ozen, MD, answers questions about her team’s research in the use of statins to help reduce the risk of cardiovascular disease and type 2 diabetes in individuals with rheumatoid arthritis.
Gulsen Ozen, MD, answers questions about her team’s research in the use of statins to help reduce the risk of cardiovascular disease and type 2 diabetes in individuals with rheumatoid arthritis.
Gulsen Ozen, MD, answers questions about her team’s research in the use of statins to help reduce the risk of cardiovascular disease and type 2 diabetes in individuals with rheumatoid arthritis.
Gulsen Ozen, MD, answers questions about her team’s research in the use of statins to help reduce the risk of cardiovascular disease and type 2 diabetes in individuals with rheumatoid arthritis.
In this Q and A, lead author Andriana Papaioannou, MD, PhD, discusses the role that identification of asthma phenotypes has in asthma diagnosis and management, the potential use of a complete blood cell...
In this Q and A, lead author Andriana Papaioannou, MD, PhD, discusses the role that identification of asthma phenotypes has in asthma diagnosis and management, the potential use of a complete blood cell...
In this Q and A, lead author Andriana Papaioannou, MD, PhD, discusses the role that identification of asthma phenotypes has in asthma diagnosis and management, the potential use of a complete blood cell...
In this Q and A, lead author Andriana Papaioannou, MD, PhD, discusses the role that identification of asthma phenotypes has in asthma diagnosis and management, the potential use of a complete blood cell...
In this Q and A, lead author Andriana Papaioannou, MD, PhD, discusses the role that identification of asthma phenotypes has in asthma diagnosis and management, the potential use of a complete blood cell...
In this Q and A, lead author Andriana Papaioannou, MD, PhD, discusses the role that identification of asthma phenotypes has in asthma diagnosis and management, the potential use of a complete blood cell...
